Thu, Dec 18, 2014, 6:07 AM EST - U.S. Markets open in 3 hrs 23 mins

Recent

% | $
Quotes you view appear here for quick access.

Ampio Pharmaceuticals, Inc. Message Board

  • racavalli racavalli Oct 15, 2013 11:08 AM Flag

    Investors don't yet realize today's announcement about HSA is clear signal Ampion will be approved

    If Ampio were uncertain to any degree that Ampion may not be approved, they certainly would not commit to an agreement for the supply of enough HSA to provide Ampion treatment for the entire OAK population.

    There are so many clues that it again brings us back to why doesn't Ampio rally in the face of bullish news that would rocket any stock.

    It is the plain and simple fact that they have no big name banker endorsing their shares. Absent a big banker, investors will always be very reluctant to take a position until some major event occurs and this will keep shares undervalued.

    Comparison to ACAD and AEGR indicate AMPE shares should be selling over $50 today making AMPE an extremely undervalued company.

    Use this opportunity to accumulate a sure thing.

    Ampio is a sure thing and they don't come any better risk to reward ratio.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Cav., You are brilliant! Love AMPE.

      Sentiment: Strong Buy

      • 1 Reply to agnewpeters
      • Thanks for the compliment, but it takes one to know one.

        In my strong opinion, you have found the biggest winner of the next decade in the entire market that investors and traders will begin to center their focus on in just a few months or less.

        Can't give you names, but suffice to say that some of the best known biotech investors are trying to quietly pick up all the stock they can get their hands on here in the 7's 8's and 9's without putting shares up in price. The big buyers don't want shares to rise until they get enough for themselves.

        If you buy and hold for at least three years, you will become very wealthy.

        Sentiment: Strong Buy

    • Rac,

      Question on the Oct 29th FDA meeting. Is it possible to get an FDA approval of Ampion from this meeting without having to undertake a larger Phase 3 trial??? Just trying to see if it was POSSIBLE, although I think probably un-likely

 
AMPE
3.57+0.280(+8.51%)Dec 17 4:06 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.